Abstract
OBJECTIVES: We evaluated the performance of blood and fecal biomarkers for differentiating between endoscopic inflammation and mucosal healing, clinically active disease and sustained clinical remission and determined the predictive value for a flare in patients with ulcerative colitis (UC). METHODS: Clinical activity Index (CAI), fecal lactoferrin (FLA), calprotectin (CAL), PMN-elastase (PMN-e), CRP, WBC, endoscopic index (EI) and UC-Disease activity Index (DAI) were determined repeatedly during 12-months and at acute flares. RESULTS: Of 91 patients (45 female; mean age 48.1±13.4 years) entering in remission, 42 (46%) patients developed a clinical flare. A total of 529 CAI and 179 EI assessments were performed. Median levels for active disease confirmed by EI (n=35) vs clinical remission with endoscopic inflammation (n=37) vs mucosal healing (n=107) for FLA were 44/37/4µg/g, CAL 25/20/10µg/g (both pCONCLUSIONS: Fecal biomarkers FLA, CAL and PMN-e were able to distinguish between UC patients with mucosal healing from clinical remission and mild disease, showed significant correlations with endoscopy and were predictive of a flare.

This publication has 45 references indexed in Scilit: